For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of Vyndamax and the formulated version represents a true advancement . These innovative therapies stabilize the transthyretin protein, slowing its harmful build-up and reducing the im